Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Eribulin mesilate added to chemotherapy in patients with bladder cancer

Feb. 10, 2012

Sanofi synthesizes new fibroblast growth factor receptor antagonists

Feb. 10, 2012

Prometheus Laboratories enters collaboration with leading pharmaceutical company

Feb. 9, 2012

RedHill receives approval from Health Canada to begin RHB-102 trial

Feb. 9, 2012

Detailed results presented of phase III regorafenib study

Feb. 9, 2012

FDA grants priority review for pertuzumab

Feb. 8, 2012

Bio-Path completes treatment of second cohort in BP-100-1.01 study

Feb. 8, 2012

Erivedge launched in U.S.

Feb. 8, 2012

Japanese authorities remove condition for approval of Tarceva in NSCLC

Feb. 8, 2012

New vaccines for human papillomavirus prepared in China

Feb. 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...